A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

Clinical trial NCT07256223 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07256223
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Cancer (ccRCC)Liver Metastasis

Start date: 2025-12-01
Primary completion: 2027-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.